JPRN-jRCT2080223725未知2 期
Early Phase 2 Clinical Study of JTS-661 - Efficacy and Safety Study
JAPAN TABACCO INC.0 个研究点目标入组 240 人开始时间: 2017年11月21日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old（—）
- 性别
- All
入选标准
- •Inadequate response to current therapies
- •- Numerical rating scale score of 6 or more
排除标准
- 未提供
研究者
相似试验
未知
1 期
Phase 1 Clinical Study of JTS-661 - Pharmacokinetic Study in Patients on HemodialysisJapanese patients with CKD on maintenance hemodialysisJPRN-jRCT2080223686JAPAN TABACCO INC.6
未知
2 期
The early Phase 2 clinical study of JTS-653 in Post-Herpetic NeuralgiaPost-Herpetic NeuralgiaJPRN-jRCT2080221142JAPAN TABACCO INC.160
招募中
2 期
A Clinical Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of PRAX-944 in Essential Tremor - Part BACTRN12622000408785Praxis Precision Medicines12
招募中
2 期
A Clinical Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of PRAX-944 in Essential TremorACTRN12619001052123Praxis Precision Medicines12
已完成
2 期
Phase II Clinical Study Evaluating the Efficacy and Safety of Cetuximab Rechallenge in Patients with Wild-Type RAS, Unresectable, Progressive/Recurrent Colorectal Cancer Refractory to Fluoropyrimidines, Oxaliplatin, Irinotecan, Cetuximab and Bevacizumab: The E-Rechallenge TrialColorectal cancerJPRN-UMIN000016439Public Health Research Foundation50